0 NYSE Companies - November 4, 2024Nordic American Tankers Ltd (NYSE: NAT) – Result from US presidential election has no impact on NATMonday, November 4, 2024 Dear Shareholders and Investors, We would note that we don’t expect there will be a noticeable immediate […]Read More
0 Canadian Stock Exchange News - November 4, 2024Metasphere Updates on Strategic Projects and Plans for Future DevelopmentsVANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) — Metasphere Labs Inc. (“Metasphere” or the “Company”) (CSE: LABZ) (OTC: LABZF) […]Read More
0 TSX Venture News - November 4, 2024VR Resources Augments Non-Brokered Private Placement with Flow Through ComponentTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. […]Read More
0 NASDAQ Companies - November 4, 2024Data Storage Corporation Provides Letter to Shareholders Highlighting Recent Achievements within CloudFirst Technologies SubsidiaryMELVILLE, N.Y., Nov. 04, 2024 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of […]Read More
0 Canadian Stock Exchange News - November 4, 2024Treatment.com AI Announces Release of New Medical Education Suite (MES) and Update on the AI Assessment Symposium 1st November, 2024●Treatment.com AI announces expanded and updated MES new releases ●Lead commercial participant at Global/North American Symposium on AI Assessment in […]Read More
0 NASDAQ Companies - November 4, 2024Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOhtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more than 2,200 unique […]Read More
0 NYSE Companies - November 4, 2024QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnosticsGermantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today […]Read More
0 NYSE Companies - November 4, 2024QIAGEN erhält FDA-Zulassung für QIAstat-Dx Meningitis/ Enzephalitis-Panel zur Unterstützung der NotfalldiagnostikGERMANTOWN, Maryland und VENLO, Niederlande, Nov. 04, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute […]Read More